NumFin

Yixintang Pharmaceutical Group Co., Ltd.

符号: 002727.SZ

SHZ

18.75

CNY

今天的市场价格

  • 23.9311

    市盈率

  • 0.6980

    PEG比率

  • 11.17B

    MRK市值

  • 0.02%

    DIV收益率

Yixintang Pharmaceutical Group Co., Ltd. (002727-SZ) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Yixintang Pharmaceutical Group Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

balance-sheet.row.cash-and-short-term-investments

03895.335202532.4
1624
1459.5
1351.9
2196
1594.7
1033.9
1056.3
520.4
386.1
386.5
378.6
216.6

balance-sheet.row.short-term-investments

0219.78.4297.3
-552.1
-493.9
81
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

01991.724111777.5
1422.5
1160.9
1192.1
1160.8
1100.1
907.4
660.4
562
404.9
303.9
256.5
195.4

balance-sheet.row.inventory

03852.63387.43317
2194.5
2028
1866
1626.3
1373.4
1024.3
766.4
608
448.7
401.1
316.9
212.6

balance-sheet.row.other-current-assets

0153.3139.265.5
1477.1
959.3
646.9
13.1
325.1
48
-84.2
-65.5
-47.5
-38.1
-35.5
-24.4

balance-sheet.row.total-current-assets

09892.99457.67692.4
6718
5607.8
5056.8
4996.2
4393.4
3013.6
2398.9
1625
1192.3
1053.4
916.6
600.2

balance-sheet.row.property-plant-equipment-net

03995.63993.54080
690.5
585.6
535.6
509.3
497.4
474.1
412.1
345.3
271.8
210
150.7
53.8

balance-sheet.row.goodwill

01649.61397.21380
1102.2
1061.1
1077.1
1057.7
796
497
1.5
0
0
0
0
0

balance-sheet.row.intangible-assets

0184.1165.7122.9
122.9
90.5
84.7
82.7
88.1
62
29.3
14.7
15.5
16.3
13.1
14.8

balance-sheet.row.goodwill-and-intangible-assets

01833.71562.91502.8
1225.1
1151.6
1161.8
1140.4
884.2
559
30.9
14.7
15.5
16.3
13.1
14.8

balance-sheet.row.long-term-investments

0165.3131.4-190.1
635.7
577.4
0
0
176.4
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

088.994.158.5
27.6
22.4
28.9
45
49.8
42.8
30.2
25.4
13.6
5.9
2.5
1.3

balance-sheet.row.other-non-current-assets

0670.8939.51193.8
31.4
18.1
572.6
455.7
12
96.8
69.4
62.5
31.3
22.7
21.9
15.3

balance-sheet.row.total-non-current-assets

06754.56721.56645
2610.3
2355
2299
2150.4
1619.8
1172.6
542.6
447.8
332.1
254.9
188.1
85.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

016647.416179.114337.3
9328.3
7962.8
7355.9
7146.6
6013.2
4186.3
2941.4
2072.8
1524.4
1308.3
1104.7
685.4

balance-sheet.row.account-payables

02560.24328.83805.9
2875.8
2316.1
2031.9
1699.7
1513.7
1065.7
722.7
680.1
493.4
449.4
373.9
237.7

balance-sheet.row.short-term-debt

03333.91335.51143.9
60.1
0
798.9
100
0.7
625
0
220
156
195.3
180.2
110.8

balance-sheet.row.tax-payables

081.4250.4164.1
105.8
129.3
158.1
146.1
22
52
27.4
28.7
14.5
8.9
27.9
24

balance-sheet.row.long-term-debt-total

01552.21758.51764.1
1795.5
482.8
0
796.5
794.2
0
0
0
0
3.3
3.3
6.8

Deferred Revenue Non Current

01.212.213.3
15.8
39.2
17.2
13.6
10
6.4
3
3.2
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01191.91055.812.7
8.6
74.1
458.3
842.8
804.9
4.4
133.1
8.2
4.5
1.6
0.6
0.5

balance-sheet.row.total-non-current-liabilities

01557.31774.71781
15.8
540.2
17.2
810.2
804.3
6.4
3
3.2
2.2
5.3
5.3
6.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01552.21756.71729
1795.5
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

08757.18651.57664.8
3547.8
3366.6
3306.4
3452.7
3515.1
1913.3
858.7
1022.7
713.6
679.5
607.3
422.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0596596596.2
595.3
567.8
567.8
567.8
520.6
260.3
260.3
195.2
195.2
195.2
195.2
175.7

balance-sheet.row.retained-earnings

04646.44335.43504.2
2834.4
2268.4
1876.3
1561.7
1272.7
1074.5
906.4
627.7
405.1
237.1
113.3
49.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0377.8424.9405.6
279.8
356.6
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02125.82069.82071.7
2056
1402.2
1601.5
1564.5
703.1
938.2
916
224.3
206.1
191.5
181
33.2

balance-sheet.row.total-stockholders-equity

077467426.16577.7
5765.4
4594.9
4045.6
3693.9
2496.4
2273
2082.7
1047.2
806.4
623.8
489.5
258.2

balance-sheet.row.total-liabilities-and-stockholders-equity

016647.416179.114337.3
9328.3
7962.8
7355.9
7146.6
6013.2
4186.3
2941.4
2072.8
1524.4
1308.3
1104.7
685.4

balance-sheet.row.minority-interest

0131101.494.8
15.1
1.2
4
0
1.8
0
0
2.9
4.4
5
8
4.6

balance-sheet.row.total-equity

078777527.66672.5
5780.5
4596.2
4049.5
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0385139.8107.2
83.6
83.5
81
12
176.4
0
3.9
3.4
2.9
2.7
2.7
2.5

balance-sheet.row.total-debt

04886.130942908
60.1
482.8
798.9
896.5
794.9
625
0
220
156
198.5
180.2
110.8

balance-sheet.row.net-debt

01210.5-417.6672.9
-1564
-976.7
-553
-1299.5
-799.8
-408.9
-1056.3
-300.4
-230.1
-188
-198.3
-105.8

现金流量表

在 Yixintang Pharmaceutical Group Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

cash-flows.row.net-income

0549.41013917.2
789.2
603.3
519.8
422.7
353.6
346.4
295
239.4
182
132.8
102.9
84.8

cash-flows.row.depreciation-and-amortization

001000.61087.8
79.8
73.4
74.4
72.9
66.6
51.5
37.4
24.7
22.3
19.3
0
0

cash-flows.row.deferred-income-tax

00-35.1-27.3
-23.4
3.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0014.240.4
32.4
-3.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

00-9.7-603.9
30.6
114.1
-49.1
-256.2
-234
-340.5
-214
-87.9
-83.6
-81.8
0
0

cash-flows.row.account-receivables

00-765.8-739.7
-279.4
40.8
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00-234.9-1236.8
-237.1
-206.1
-229.8
-333.8
-386
-304.3
-167.7
-165.9
-48.6
-83.9
0
0

cash-flows.row.account-payables

001026.11399.9
570.5
276
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-35.1-27.3
-23.4
3.4
180.7
77.6
151.9
-36.2
-46.3
78
-35
2.2
0
0

cash-flows.row.other-non-cash-items

0-549.4514.1377.5
124.9
192.1
90.7
151.7
6.5
128.3
57.8
52
37
31.2
-102.9
-84.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-349-391.6
-280.2
-206.9
-156
-142
-146.1
-194
-158.6
-145.4
-103.8
-97.6
-139.6
-26.9

cash-flows.row.acquisitions-net

00-4.7-65.1
3.4
1.4
-11.6
-3.5
-47.3
0
0.4
0
0
0
1.2
0

cash-flows.row.purchases-of-investments

00-980.5-1976.5
-5195
-3320.9
-3015.5
-250.7
-390
-506.7
-6.9
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

001207.22901.8
4728.6
3022.1
2358.2
518
125
12
159
0
0
0
0
0

cash-flows.row.other-investing-activites

00-94.7-336.9
-181.5
-52.7
-69.3
-407.3
-210.5
-66.5
-158.6
0.1
0.6
0.3
8.3
4.8

cash-flows.row.net-cash-used-for-investing-activites

00-221.7131.7
-924.7
-556.8
-894.3
-285.6
-668.9
-755.2
-164.7
-145.3
-103.2
-97.3
-130.1
-22.1

cash-flows.row.debt-repayment

00-207.9-137.1
-51.1
-800
-514
-850.7
-532.1
-83
-320
-186
-349.5
-282.9
-249
-111.8

cash-flows.row.common-stock-issued

0020.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-2-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-191.6-180.9
-175
-200.3
-211.6
-168.5
-133.9
-166.4
-8.6
-12.5
-12.4
-10.6
-35.4
-4.9

cash-flows.row.other-financing-activites

00-678.6-986.8
177.6
596.9
5.3
1462
1591.3
708
849
250
307
297.2
469.5
173.8

cash-flows.row.net-cash-used-provided-by-financing-activities

00-1078.2-1304.8
-48.4
-403.3
-720.4
442.8
925.4
458.6
520.5
51.5
-55
3.7
185.1
57.1

cash-flows.row.effect-of-forex-changes-on-cash

000.3-0.1
-0.2
0.1
0.5
-0.1
0.1
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

001197.5618.5
60
22.8
-978.4
548.3
449.1
-110.9
531.9
134.4
-0.5
8
161.9
90.3

cash-flows.row.cash-at-end-of-period

02859.52859.51661.9
1043.5
983.4
960.6
1939
1390.7
941.5
1052.4
520.4
386.1
386.5
378.6
216.6

cash-flows.row.cash-at-beginning-of-period

02859.51661.91043.5
983.4
960.6
1939
1390.7
941.6
1052.4
520.4
386.1
386.5
378.6
216.6
126.3

cash-flows.row.operating-cash-flow

002497.11791.7
1033.4
982.9
635.8
391.2
192.6
185.8
176.2
228.2
157.7
101.6
0
0

cash-flows.row.capital-expenditure

00-349-391.6
-280.2
-206.9
-156
-142
-146.1
-194
-158.6
-145.4
-103.8
-97.6
-139.6
-26.9

cash-flows.row.free-cash-flow

002148.11400
753.2
776.1
479.7
249.1
46.5
-8.3
17.6
82.8
53.9
4
-139.6
-26.9

利润表行

Yixintang Pharmaceutical Group Co., Ltd. 的收入与上期相比变化了 NaN%。据报告, 002727.SZ 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

income-statement-row.row.total-revenue

017301.417431.614587.4
12656.3
10479.1
9176.3
7751.1
6249.3
5321.2
4428.4
3546.7
2842.1
2218.5
1850.2
1456

income-statement-row.row.cost-of-revenue

011750.311322.39196.5
8123
6424.1
5457
4532.5
3669.4
3090.3
2637.8
2142.5
1758
1355.9
1159.9
925

income-statement-row.row.gross-profit

055516109.35390.9
4533.3
4055
3719.2
3218.6
2579.9
2230.9
1790.6
1404.2
1084.2
862.6
690.2
531

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-106.6349.1320.6
437.6
343.3
414.3
367.8
18.5
12.8
2.4
6.4
6.3
2
2.4
-4.5

income-statement-row.row.operating-expenses

04717.54496.84091.3
3558.9
3250.3
2924.5
2574.6
2110.1
1791.6
1386.7
1117.6
867.4
694.5
559.8
414.5

income-statement-row.row.cost-and-expenses

016467.815819.113287.8
11681.9
9674.4
8381.5
7107.2
5779.5
4881.9
4024.5
3260.1
2625.4
2050.4
1719.7
1339.4

income-statement-row.row.interest-income

0-77.653.439.2
24.2
19
12.4
10.7
12.2
13.6
8.6
6.3
4.9
4
0
0

income-statement-row.row.interest-expense

0135.3147.1136.2
24.5
33.7
47.6
57.6
37.5
20.4
8.1
12.9
12.4
10
4.8
6

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-123.6-426.928.6
39
9.8
7.3
-140.5
-60.4
-49.1
-58.6
-16.6
-11.9
-10.2
-4.6
-11.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-106.6349.1320.6
437.6
343.3
414.3
367.8
18.5
12.8
2.4
6.4
6.3
2
2.4
-4.5

income-statement-row.row.total-operating-expenses

0-123.6-426.928.6
39
9.8
7.3
-140.5
-60.4
-49.1
-58.6
-16.6
-11.9
-10.2
-4.6
-11.8

income-statement-row.row.interest-expense

0135.3147.1136.2
24.5
33.7
47.6
57.6
37.5
20.4
8.1
12.9
12.4
10
4.8
6

income-statement-row.row.depreciation-and-amortization

01332.41000.61397.7
229.8
184.9
222.4
72.9
66.6
51.5
37.4
24.7
22.3
19.3
8.7
8.5

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0833.51661.91067.9
917.9
739.2
684.3
687.4
392.6
379
344.4
264.3
198.9
156.3
123.9
109.8

income-statement-row.row.income-before-tax

0709.912351096.5
956.9
749.1
691.7
546.9
409.4
390.1
345.3
269.9
204.8
157.9
125.9
104.8

income-statement-row.row.income-tax-expense

0142.2222179.3
167.7
145.7
171.9
124.1
55.8
43.7
50.3
30.6
22.9
25.1
24.4
20

income-statement-row.row.net-income

0549.41010921.6
790
603.9
521.1
422.7
353.4
346.4
297.3
240.9
182.6
134.7
102.9
84.8
类似股票
您可能还对以下内容感兴趣：
MDVL
MedAvail Holdings, Inc..
1.8 USD
NASDAQ
3544.T
Satudora Holdings Co.,Ltd..
879 JPY
JPX
TSUSF
Tsuruha Holdings Inc..
86.95 USD
PNK
SHPPF
Shop Apotheke Europe N.V..
150.26 USD
PNK
3391.T
Tsuruha Holdings Inc..
11105 JPY
JPX
GABY.CN
GABY Inc..
0.005 CAD
CNQ
ALBHF
Alibaba Health Information Technology Limited.
0.4628 USD
PNK
WLCGF
Welcia Holdings Co., Ltd..
17.49 USD
PNK
1345.HK
China Pioneer Pharma Holdings Limited.
1.42 HKD
HKSE
OXIHF
Oxford Investments Holdings Inc..
0.000001 USD
PNK

常见问题

什么是 Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) 总资产是多少？

Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) 总资产为 16647375283.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.318.

什么是公司自由现金流？

自由现金流为 3.367.

什么是企业净利润率？

净利润率为 0.031.

企业总收入是多少？

总收入为 0.045.

什么是 Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 549441525.000.

公司总债务是多少？

债务总额为 4886107552.000.

营业费用是多少？

运营支出为 4717493463.000.

公司现金是多少？

企业现金为 0.000.